AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 221 filers reported holding AMICUS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $11,142,000 | +20.9% | 964,704 | 0.0% | 1.15% | +2.0% |
| Q3 2021 | $9,213,000 | -1.7% | 964,704 | -0.7% | 1.13% | +21.3% |
| Q2 2021 | $9,369,000 | -2.4% | 971,866 | 0.0% | 0.93% | +32.1% |
| Q1 2021 | $9,602,000 | -13.6% | 971,866 | -16.2% | 0.70% | -78.8% |
| Q4 2018 | $11,113,000 | -20.8% | 1,160,022 | 0.0% | 3.32% | -23.7% |
| Q3 2018 | $14,025,000 | -2.4% | 1,160,022 | +26.1% | 4.35% | +31.6% |
| Q2 2018 | $14,371,000 | – | 920,022 | – | 3.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |